Senior Director, Clinical Indication Lead (Oncology)
Bristol Myers Squibb
Summary
The Senior Director, Global Clinical Development serves as the Clinical Indication Lead for one or more indications of a given asset. This role is accountable for clinical strategy and execution in the given indication(s). This role leads a team of physicians and scientists in the design, execution, analysis, and interpretation of all clinical studies for respective indications of a given asset.
Job description
Key Responsibilities
Clinical Strategy & Asset Leadership
- Owns and drives clinical development strategy across given asset indications, aligned to overall asset strategy, Target Product Profile (TPP), and relevant disease area strategy.
- May lead the Clinical Development Team(s) for given indication(s) depending on program structure
- Provides clinical and disease area expertise to integrated disease area and portfolio and therapeutic level strategies
- Represents Clinical as the internal and external authority for the indication/disease area, including regulatory interactions and Business Development support.
- Engages cross-functionally with internal leaders and partners with external investigators, key opinion leaders, and patient advocacy groups.
- Presents clinical strategy, data, and risk assessments to governance bodies, health authorities, and senior leadership.
Clinical Study Design, Execution & Oversight
- Leads a team of physicians and scientists in the design, execution, analysis, and interpretation of all clinical studies for given asset indication(s)
- Ensures studies meet regulatory, quality, medical, and access objectives and are aligned with target label indications.
- Ensures high quality, timely delivery of innovative protocols and data packages for CSRs and Regulatory Filings; implements quality assurance plans
- Accountable for clinical content and data quality for CSRs, trial documents, regulatory submissions, briefing books, and publications.
- Oversees trial progress, proactively identifies and mitigates risk, and provides regular status and risk updates to senior management.
- Champions quality, compliance, and GCP adherence across all clinical activities, partnering with Development Operations and Compliance as needed.
Team Leadership & Talent Development
- Sets priorities aligned to program objectives and works with Clinical Asset leadership to ensure appropriate budget/resourcing
- Attracts, develops, and retains top clinical talent through effective leadership, mentoring, and training.
- Fosters a culture of scientific excellence, collaboration, innovation, and accountability.
Qualifications & Experience
- Advanced degree in Life Sciences required (PhD, PharmD, MS, RN, MD or related field, MD)
- Deep clinical and therapeutic area expertise with advanced knowledge of drug development, competitive landscape, and health authority expectations.
- 8+ years of relevant experience, including leadership in the design and execution of multiple clinical trials.
- Demonstrated success in people leadership and/or matrix leadership roles.
Requirements
- Advanced degree in Life Sciences required (PhD, PharmD, MS, RN, MD or related field, MD)
- Deep clinical and therapeutic area expertise with advanced knowledge of drug development, competitive landscape, and health authority expectations
- 8+ years of relevant experience, including leadership in the design and execution of multiple clinical trials
- Demonstrated success in people leadership and/or matrix leadership roles
Benefits
- Wellbeing Support
- Retirement Benefits
- Financial Protection Benefits
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- Flexible Time Off
- Paid Company Holidays
- Paid Sick Leave
- Paid Volunteer Days
- Summer Hours Flexibility
- Leaves of Absence
- Annual Global Shutdown
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.